These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31410788)

  • 1. Chemical Development of Therapeutic Oligonucleotides.
    Lundin KE; Gissberg O; Smith CIE; Zain R
    Methods Mol Biol; 2019; 2036():3-16. PubMed ID: 31410788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry of Peptide-Oligonucleotide Conjugates: A Review.
    Klabenkova K; Fokina A; Stetsenko D
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity and biotechnological aspects of locked nucleic acids.
    Lundin KE; Højland T; Hansen BR; Persson R; Bramsen JB; Kjems J; Koch T; Wengel J; Smith CI
    Adv Genet; 2013; 82():47-107. PubMed ID: 23721720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole-linked Nucleic Acids: Synthesis, Therapeutics and Synthetic Biology Applications.
    Sharma VK; Mangla P; Singh SK; Prasad AK
    Curr Org Synth; 2024; 21(4):436-455. PubMed ID: 37138439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA).
    Kaur H; Babu BR; Maiti S
    Chem Rev; 2007 Nov; 107(11):4672-97. PubMed ID: 17944519
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic Oligonucleotides: State of the Art.
    Smith CIE; Zain R
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():605-630. PubMed ID: 30285540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomeric nucleic acids as antivirals.
    Mescalchin A; Restle T
    Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2'β-Fluoro-Tricyclo Nucleic Acids (2'F-tc-ANA): Thermal Duplex Stability, Structural Studies, and RNase H Activation.
    Istrate A; Katolik A; Istrate A; Leumann CJ
    Chemistry; 2017 Aug; 23(43):10310-10318. PubMed ID: 28477335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.
    Astakhova IK; Wengel J
    Acc Chem Res; 2014 Jun; 47(6):1768-77. PubMed ID: 24749544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
    Torres AG; Threlfall RN; Gait MJ
    Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
    Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
    Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and properties of a novel modified nucleic acid, 2'-N-methanesulfonyl-2'-amino-locked nucleic acid.
    Sawamoto H; Sasaki T; Takegawa-Araki T; Utsugi M; Furukawa H; Hirakawa Y; Yamairi F; Kurita T; Murahashi K; Yamada K; Ohta T; Kumagai S; Takemiya A; Obika S; Kotera J
    Bioorg Med Chem Lett; 2023 May; 88():129289. PubMed ID: 37068560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids.
    Shimo T; Nakatsuji Y; Tachibana K; Obika S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.